tiprankstipranks
Navidea Biopharmaceuticals (NAVB)
OTHER OTC:NAVB
US Market

Navidea (NAVB) Income Statement

Compare
316 Followers

Navidea Income Statement

Last quarter (Q3 2023), Navidea's total revenue was $0.00, a decrease of -100.00% from the same quarter last year. In Q3, Navidea's net income was $-2.26M. See Navidea’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 22Dec 21Dec 20Dec 19Dec 18
Total Revenue
$ 65.65K$ 531.51K$ 915.01K$ 26.62K$ 322.52K
Gross Profit
$ -119.30K$ 332.68K$ 913.97K$ 19.95K$ 225.88K
Operating Expenses
$ 13.93M$ 12.59M$ 11.63M$ 10.98M$ 11.07M
Depreciation and Amortization
$ 95.82K$ 198.83K$ 190.58K$ 144.51K$ 150.38K
EBITDA
$ -13.88M$ -11.51M$ -10.64M$ -10.82M$ -10.85M
Operating Income
$ -14.05M$ -12.06M$ -10.71M$ -10.96M$ -10.85M
Other Income/Expenses
$ -1.13M$ 345.52K$ -10.51K$ 17.68K$ -5.32M
Pretax Income
$ -15.18M$ -11.71M$ -10.72M$ -10.94M$ -16.17M
Net Income
$ -15.18M$ -11.73M$ -10.64M$ -10.95M$ -16.13M
Per Share Metrics
$ ―$ ―$ ―$ ―$ ―
Basic EPS
$ -0.59$ -0.40$ -0.45$ -0.76$ -1.89
Diluted EPS
$ -0.56$ -0.40$ -0.45$ -0.76$ -1.89
Weighted Average Shares Outstanding
29.34M 29.34M 23.90M 14.39M 8.53M
Weighted Average Shares Outstanding (Diluted)
30.90M 29.34M 23.90M 14.39M 8.53M
Currency in USD

Navidea Earnings and Revenue History

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis